AlphaYou
Overview
Smart money at a glance
Filings to Oct 7, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 2 added, 0 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 7- Open
- $7.62
- 52-wk high
- $9.42
- High
- $7.92
- 52-wk low
- $2.55
- Low
- $7.50
- Prev close
- $7.50
- Mkt cap
- $3.16B
- Volume
- 1.91M
- Fwd P/E
- 370.4x
- Beta
- 0.54
- P/S
- 15.1x
- P/B
- 5.4x
- Profit margin
- -37.1%
- Op margin
- -29.4%
- ROE
- -33.1%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about MRVI filings
Are insiders buying or selling Maravai Lifesciences Holdings Inc (MRVI) stock?
Neither. Maravai Lifesciences Holdings Inc (MRVI) insiders filed no open-market purchases or sales in the 90 days to Oct 7, 2026, according to SEC Form 4 filings.
Which members of Congress have traded MRVI recently?
None. No member of Congress disclosed a MRVI trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this MRVI smart-money data?
This summary uses filings available on Oct 7, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (2)
- MI
Millennium
$35.9M
added
- JC
JPMorgan Chase
$15.5M
added
What insiders are doing
Sells (1)
- OK
Oreshack Kurt
$254K
sold
How top traders are positioned
No tracked top-trader positions in MRVI right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in $0.02 a share above what analysts expected.
Last report
Aug 6, 2026
Period ending
Jun 30, 2026
Adjusted EPS
-$0.04 expected
Revenue
No reported revenue on record
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 6, 2026 | -$0.02 / -$0.04Yahoo Finance | +$0.02 beat | Unavailable | Unavailable |
| Mar 31, 2026 | May 7, 2026 | $0.01 / -$0.05Yahoo Finance | +$0.06 beat | Unavailable | Unavailable |
| Dec 31, 2025 | Feb 25, 2026 | -$0.04 / -$0.07Yahoo Finance | +$0.03 beat | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 6, 2025 | -$0.08 / -$0.08Yahoo Finance | +$0.00 beat | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 11, 2025 | -$0.08 / -$0.07Alpha Vantage | -$0.01 miss | Unavailable | Unavailable |
| Mar 31, 2025 | May 12, 2025 | -$0.08 / -$0.07Alpha Vantage | -$0.01 miss | Unavailable | Unavailable |
| Dec 31, 2024 | Mar 18, 2025 | -$0.06 / -$0.04Alpha Vantage | -$0.02 miss | Unavailable | Unavailable |
| Sep 30, 2024 | Nov 7, 2024 | -$0.02 / -$0.01Alpha Vantage | -$0.01 miss | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Reports Nov 5, 2026, in 29 days
Financials
Is the business strong?
This company is not yet profitable.
- Net margin
- -37.1%
- Forward P/E
- 370.37
- Market cap
- $3.2B
Valuation
- P/S15.11
- P/B5.37
Quality
- Operating margin-29.4%
- ROE-33.1%
- ROA-5.7%
Growth
- Beta0.54
Technicals
Price structure
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace